TRON gGmbH
TRON – Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz gemeinnützige GmbH
General information
TRON gGmbH
Freiligrathstraße 12
55131 Mainz, Rhineland-Palatinate
Germany
Contact person: Michael Ludorf, Managing Director
Company main phone: +49 (6131) 21610
Company main fax: +49 (6131) 2161100
Website: https://tron-mainz.de
Freiligrathstraße 12
55131 Mainz, Rhineland-Palatinate
Germany
Contact person: Michael Ludorf, Managing Director
Company main phone: +49 (6131) 21610
Company main fax: +49 (6131) 2161100
Website: https://tron-mainz.de
| Year founded: | 2010 |
| Source of foundation: | Independent foundation |
Corporate description / mission:
TRON is a transdisciplinary, not-for-profit research organization based at the Technologiezentrum Mainz. TRON pursues new diagnostics and drugs for the treatment of cancer and other severe diseases with a high medical need. Their focus is translating scientific insights into clinical practice and developing them for commercialization.
TRON is a transdisciplinary, not-for-profit research organization based at the Technologiezentrum Mainz. TRON pursues new diagnostics and drugs for the treatment of cancer and other severe diseases with a high medical need. Their focus is translating scientific insights into clinical practice and developing them for commercialization.
State of ownership: Private / independent
Headquarters: HQ: Yes
Headquarters: HQ: Yes
Categorization
| Sector: |
|
| Subsector: |
|
| Primary therapeutic areas: |
|
| Business model: |
|
| Customer segments: |
|
Summary Products / Services / Technologies
Description of products:
TRON conducts collaborative research into immunological mechanisms and therapeutic modulation of the immune system. Specializing in cancer immunology and genomics, they identify and characterize disease-relevant molecular targets, including developing tailored bioinformatical and novel biostatistical approaches.
They design and improve technologies for biomarker discovery and biopharmaceutical drug development.
TRON conducts collaborative research into immunological mechanisms and therapeutic modulation of the immune system. Specializing in cancer immunology and genomics, they identify and characterize disease-relevant molecular targets, including developing tailored bioinformatical and novel biostatistical approaches.
They design and improve technologies for biomarker discovery and biopharmaceutical drug development.
© 2024 Biotechgate by Venture Valuation